Cargando…
The genes controlling normal function of citrate and spermine secretion are lost in aggressive prostate cancer and prostate model systems
High secretion of the metabolites citrate and spermine is a unique hallmark for normal prostate epithelial cells, and is reduced in aggressive prostate cancer. However, the identity of the genes controlling this biological process is mostly unknown. In this study, we have created a gene signature of...
Autores principales: | Rye, Morten Beck, Krossa, Sebastian, Hall, Martina, van Mourik, Casper, Bathen, Tone F., Drabløs, Finn, Tessem, May-Britt, Bertilsson, Helena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189124/ https://www.ncbi.nlm.nih.gov/pubmed/35707723 http://dx.doi.org/10.1016/j.isci.2022.104451 |
Ejemplares similares
-
Spermine and Citrate as Metabolic Biomarkers for Assessing Prostate Cancer Aggressiveness
por: Giskeødegård, Guro F., et al.
Publicado: (2013) -
A Balanced Tissue Composition Reveals New Metabolic and Gene Expression Markers in Prostate Cancer
por: Tessem, May-Britt, et al.
Publicado: (2016) -
Gene signatures ESC, MYC and ERG-fusion are early markers of a potentially dangerous subtype of prostate cancer
por: Rye, Morten Beck, et al.
Publicado: (2014) -
SFRP4 gene expression is increased in aggressive prostate cancer
por: Sandsmark, Elise, et al.
Publicado: (2017) -
Cholesterol synthesis pathway genes in prostate cancer are transcriptionally downregulated when tissue confounding is minimized
por: Rye, Morten Beck, et al.
Publicado: (2018)